Filter by: Subject

Filter by: Subject

Results Per Page:

PET imaging (2)
Prevention (2)
Pandemic (1)
Pandemics (1)
Parathyroid (1)
Patient safety (1)
Patient treatment (1)
Patienten management (1)
Pedicle screws (1)
People living with HIV (PLWHIV) (1)
People living with human immunodeficiency virus (PLHIV) (1)
Peptide mapping (1)
Peptide radiolabeling (1)
Peptidoglycan (1)
Performance improvement (1)
Personalised medicine (1)
PET-based response assessment of radiotherapy (1)
PET/computed tomography (1)
PET/CT imaging (1)
PET/CT-imaging (1)
Phenylacetic acid metabolism (1)
Physico-chemical characterization (1)
Pitfall (1)
Plasma homocysteine (1)
Plasmodium falciparum (1)
Point-of-care (POC) (1)
Poly(D,L-lactide-co-glycolide) (PLGA) (1)
Positron emission tomography/computed tomography (PET/CT) (1)
Postoperative spine infection (1)
Precautions (1)
Preclinical imaging (1)
Precursor (1)
Preprepared (1)
Primary prostate carcinoma (PPC) (1)
Pro-inflammatory cytokines (1)
Probe-to-bone test (1)
Processing methods (1)
Professional practice standards (1)
Prognosis (1)
Programmed death protein-1 (PD-1) (1)
Progression-free survival (PFS) (1)
Prostate-specific antigen (1)
Prostate-specific antigen (PSA) (1)
Prostate-specific membrane antigen expression (1)
Prostate-specific membrane antigen radioligand therapy (PSMA-RLT) (1)
Prosthetic valve (1)
Protein (1)
Protein-losing enteropathies (1)
Protein-losing enteropathy (1)
Proteins (1)
PSA response (1)
PSMA PET/CT (1)
PSMA-617 (1)
PSMA-based alpha therapy (PAT) (1)
Pulmonary (1)
Pulmonary perfusion (1)
Pulmonary thromboembolism (1)
Pulmonary tuberculosis (1)